ENGLEWOOD, Colo., June 2, 2022 /PRNewswire/ — Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the treatment of pain resulting from osteoarthritis in the knee and potentially other articular…
News
ICE Climate Data Available via the Investortools Platform Enhances Climate Risk Analysis for Fixed Income Investors
ATLANTA & COLORADO SPRINGS, Colo.–(BUSINESS WIRE)–Intercontinental Exchange, Inc. (NYSE: ICE), a leading global provider of technology and data, and Investortools, Inc., a leading provider of fixed-income software solutions supporting over $1 trillion in AUM, today […]
News
Vaccine for Newborns has Nearly Eliminated U.S. Childhood Hepatitis B Infections
Before the United States began vaccinating all infants at birth with the hepatitis B vaccine in 1991, around 18,000 children every year contracted the virus before their 10th birthday – about half of them at birth. About […]
News
Fitzsimons Innovation Community – Building a Life Sciences Pipeline: Access to Capital
In Fitzsimons Innovation Community’s blog series, Building a Life Sciences Pipeline, hear how the CU Healthcare Innovation Fund provided strategic value for Arrive Health, and how they’ve been successful at raising capital to build and […]
